Coronavirus Vaccine: US te Moderna para Covid vaccine phase-3 clinical trial soruh hoishe

New York, July 28, 2020.  Pharmaceutical company Moderna para phase-3 clinical trial kura soruh hoishe. Tai khan etu vaccine ke investigate kurikena  mRNA-1273 nam ase koishe aro etu vaccine tuh Covid-19 virus ke protect kuriboli bona ase. Etu trial tuh US clinical research sites te 30,000 manuh (participants) kuan khan Covid-19 bemar nai, tai khan logot loboli ase koishe. “United States laga National Institute of Allergy and Infectious Diseases (NIAID) Anthony S. Fauci para koishe ke, early-stage clinical testing hesab te mRNA-1273 vaccine tuh safe aro immunogenic ase aro etu para Phase 3 clinical trial logot support kuri koishe. Fauci aro koishe ke, “etu scientifically rigorous, randomised, placebo-controlled trial boba tuh joti etu vaccine para Covid-19 bemari ke prevent hoikena  keman deri protection thibo saboli koishe. Moderna’s vaccine tuh Cambridge University aro NIAID, part of the National Institutes of Health (NIH) khan para be melaikena bonaishe koishe. Researchers khan laga hesab te, mRNA-1273 vaccine candidate tuh Unites States te 89 89 clinical research sites te test kuribo. Etu pithor te 24 tuh NIH Coronavirus Prevention Network (CoVPN) laga part ase koishe. Investigators khan para public health data use kurobo aro bemari thaka chaka aro bemari ola hot zones khan besaribo ase. Phase-3 blinded trial para mRNA-1273 laga safety tuh sabo aro tawai tuita(2) lowah beche vaccine para tuh symptomatic Covid-19 bemari tuh prevent hoi naa naihoi saboli ase. Etu samay, Volunteers khan tuh tuita(2) intramuscular injections 28 din beche te thibo. Participants khan ke antas para mRNA-127 laga 100-microgram injections lobo nohoile tuita(2) saline lobo.Trail para jawab be thiya tuh joti COVID-19 bemari manuh ke bacha-boli parey aro ekta tawai para symptomatic COVID-19 bemari ke be safe hoina nahoi kotha koishe. Etu samay, Moderna tuh US government’s Biomedical Advanced Research and Development Authority (BARDA) logot $472 million award paishe, etu tuh Covid-19 vaccine candidate khan logot Phase-3 clinical trial nemite ase koishe.